Nucala 100 MG/ML syringeml

Ended Awarded

Contract number
SPE2DR26FKGA0
Awardee
Awarding agency
Obligated
$7,727

Award facts

Contract value 100% obligated
$7,727.36 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on July 10, 2026, for Nucala 100 mg/ml syringes with a ceiling value of $7,727.36 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The delivery order is priced on a firm fixed-price basis with an ultimate completion date of July 13, 2026.

Quick answers

Who was awarded contract SPE2DR26FKGA0?

SPE2DR26FKGA0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 10, 2026.

How much is contract SPE2DR26FKGA0 worth?

The government has obligated $7,727 on SPE2DR26FKGA0.

Is contract SPE2DR26FKGA0 an order under another contract?

Yes. SPE2DR26FKGA0 is a delivery order under SPE2DR25D9362, an indefinite delivery contract.

Was contract SPE2DR26FKGA0 competed?

The extent of competition for SPE2DR26FKGA0 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award